PMC:7161517 / 21764-21935 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T129","span":{"begin":85,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A129","pred":"fma_id","subj":"T129","obj":"http://purl.org/sig/ont/fma/fma66326"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T66","span":{"begin":85,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A66","pred":"uberon_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/UBERON_0002012"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T89","span":{"begin":85,"end":116},"obj":"Disease"},{"id":"T91","span":{"begin":104,"end":116},"obj":"Disease"}],"attributes":[{"id":"A89","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0015924"},{"id":"A90","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0024533"},{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T215","span":{"begin":79,"end":84},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T216","span":{"begin":85,"end":103},"obj":"http://purl.obolibrary.org/obo/UBERON_0002012"},{"id":"T217","span":{"begin":85,"end":103},"obj":"http://www.ebi.ac.uk/efo/EFO_0001399"},{"id":"T218","span":{"begin":157,"end":165},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T30","span":{"begin":85,"end":116},"obj":"Phenotype"}],"attributes":[{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0002092"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T759","span":{"begin":79,"end":84},"obj":"SP_6;NCBITaxon:9606"},{"id":"T760","span":{"begin":85,"end":103},"obj":"UBERON:0002012"},{"id":"T761","span":{"begin":152,"end":156},"obj":"G_3;PG_10;PR:000003622"},{"id":"T89094","span":{"begin":33,"end":38},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T42418","span":{"begin":65,"end":79},"obj":"GO:0010467"},{"id":"T33738","span":{"begin":83,"end":87},"obj":"G_3;PG_10;PR:000003622"},{"id":"T80753","span":{"begin":88,"end":95},"obj":"PR:000036013"},{"id":"T25938","span":{"begin":99,"end":106},"obj":"UBERON:0000948"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"950","span":{"begin":152,"end":156},"obj":"Gene"},{"id":"951","span":{"begin":79,"end":84},"obj":"Species"},{"id":"952","span":{"begin":69,"end":75},"obj":"Chemical"},{"id":"955","span":{"begin":85,"end":116},"obj":"Disease"}],"attributes":[{"id":"A950","pred":"tao:has_database_id","subj":"950","obj":"Gene:59272"},{"id":"A951","pred":"tao:has_database_id","subj":"951","obj":"Tax:9606"},{"id":"A955","pred":"tao:has_database_id","subj":"955","obj":"MESH:D000081029"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}

{"project":"2_test","denotations":[{"id":"32305401-29903860-55252979","span":{"begin":167,"end":169},"obj":"29903860"}],"text":"An additional pilot study (NCT101884051) investigated the effects of rhACE2 in human pulmonary arterial hypertension, which is characterized by reduced ACE2 activity (58)."}